ArticleJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2026
Measuring atrioventricular valve regurgitation in Fontan patients using cardiovascular magnetic resonance imaging and the association with clinical outcomes: A FORCE Study.
Article in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundAtrioventricular valve regurgitation (AVVR) predicts long-term post-Fontan adverse outcomes. Literature on the measurement and prognostic value of quantitative AVVR assessment using cardiovascular magnetic resonance imaging (CMR) is limited. This study compared echocardiographic AVVR measurements with measurements by CMR, and investigated their association with clinical outcomes using the multi-center Fontan Outcome Registry using Clinical Examination (FORCE).
methodsPatients with an examiner-reported AVVR severity category from CMR (AVVR
resultsExactly 2309 Fontan patients were included, with a median age at CMR of 15.7 years and (971/2309) 42.1% female. Categorical AVVR severity reported by CMR was significantly associated with adverse outcomes (adjusted HR 2.10, 95% CI [1.38, 3.19] for moderate and 4.61 [2.80, 7.58] for severe AVVR), comparable to AVVR reported by echocardiography. AVVR
conclusionsThis is the first study evaluating different CMR measurements of AVVR in a large cohort of Fontan patients. Compared with AVVR
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.